These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 28975126)
41. The results of modern surgical therapy for multiple primary lung cancers. Adebonojo SA; Moritz DM; Danby CA Chest; 1997 Sep; 112(3):693-701. PubMed ID: 9315801 [TBL] [Abstract][Full Text] [Related]
43. Second primary malignancies in multiple myeloma: an overview and IMWG consensus. Musto P; Anderson KC; Attal M; Richardson PG; Badros A; Hou J; Comenzo R; Du J; Durie BGM; San Miguel J; Einsele H; Chen WM; Garderet L; Pietrantuono G; Hillengass J; Kyle RA; Moreau P; Lahuerta JJ; Landgren O; Ludwig H; Larocca A; Mahindra A; Cavo M; Mazumder A; McCarthy PL; Nouel A; Rajkumar SV; Reiman A; Riva E; Sezer O; Terpos E; Turesson I; Usmani S; Weiss BM; Palumbo A; Ann Oncol; 2017 Feb; 28(2):228-245. PubMed ID: 27864218 [TBL] [Abstract][Full Text] [Related]
44. Survival in second primary malignancies of patients with head and neck cancer. Di Martino E; Sellhaus B; Hausmann R; Minkenberg R; Lohmann M; Esthofen MW J Laryngol Otol; 2002 Oct; 116(10):831-8. PubMed ID: 12437840 [TBL] [Abstract][Full Text] [Related]
45. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations. Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129 [TBL] [Abstract][Full Text] [Related]
46. Type of second primary malignancy after achieving complete response by definitive chemoradiation therapy in patients with esophageal squamous cell carcinoma. Yamaguchi T; Kato K; Nagashima K; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Ito Y; Itami J; Boku N; Higuchi K Int J Clin Oncol; 2018 Aug; 23(4):652-658. PubMed ID: 29520523 [TBL] [Abstract][Full Text] [Related]
47. The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative (131)I dose over 37 GBq. Khang AR; Cho SW; Choi HS; Ahn HY; Yoo WS; Kim KW; Kang KW; Yi KH; Park DJ; Lee DS; Chung JK; Cho BY; Park YJ Clin Endocrinol (Oxf); 2015 Jul; 83(1):117-23. PubMed ID: 25115234 [TBL] [Abstract][Full Text] [Related]
48. Multiple primary cancers: An enigma. Jena A; Patnayak R; Lakshmi AY; Manilal B; Reddy MK South Asian J Cancer; 2016; 5(1):29-32. PubMed ID: 27169120 [TBL] [Abstract][Full Text] [Related]
49. Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy. Zhang B; Guo K; Zheng X; Sun L; Shen M; Ruan S Front Oncol; 2020; 10():1154. PubMed ID: 32766153 [No Abstract] [Full Text] [Related]
50. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer. Marti JL; Jain KS; Morris LG Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829 [TBL] [Abstract][Full Text] [Related]
51. Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study. Wang W Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138756 [TBL] [Abstract][Full Text] [Related]
52. Incidence of Second Primary Malignancies in Patients with Neuroendocrine Tumours. Clift AK; Drymousis P; Al-Nahhas A; Wasan H; Martin J; Holm S; Frilling A Neuroendocrinology; 2015; 102(1-2):26-32. PubMed ID: 25824138 [TBL] [Abstract][Full Text] [Related]
53. Prognostic impact of synchronous second primary malignancies on the overall survival of patients with metastatic prostate cancer. Koo KC; Yoo H; Kim KH; Park SU; Han KS; Rha KH; Hong SJ; Yang SC; Chung BH J Urol; 2015 Apr; 193(4):1239-44. PubMed ID: 25444987 [TBL] [Abstract][Full Text] [Related]
54. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary. Géczi L; Gomez F; Bak M; Bodrogi I J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851 [TBL] [Abstract][Full Text] [Related]
55. Incidence of second primary malignancy after breast cancer and related risk factors-Is breast-conserving surgery safe? A nested case-control study. Li Z; Wang K; Shi Y; Zhang X; Wen J Int J Cancer; 2020 Jan; 146(2):352-362. PubMed ID: 30861567 [TBL] [Abstract][Full Text] [Related]
56. CML as Part of Dual Malignancies-A Retrospective Analysis: Possible Mechanisms and Review of Literature. Sahu KK; Uday Y; Bal A; Varma N; Naseem S; Khadwal A; Prakash G; Varma S; Malhotra P Indian J Hematol Blood Transfus; 2016 Dec; 32(4):392-396. PubMed ID: 27812246 [TBL] [Abstract][Full Text] [Related]
57. A Retrospective Evaluation of Clinical Profile of Second Primary Head and Neck Cancer. Kaur P; Bansal N; Kumar JV; Khurana A; Chauhan A J Clin Diagn Res; 2016 Oct; 10(10):XC10-XC14. PubMed ID: 27891442 [TBL] [Abstract][Full Text] [Related]
58. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study. Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624 [TBL] [Abstract][Full Text] [Related]
59. Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. Ng SP; Pollard C; Kamal M; Ayoub Z; Garden AS; Bahig H; Gunn GB; Frank SJ; Skinner HD; Phan J; Berends J; Morrison WH; Johnson JM; Ferrarotto R; Sturgis EM; Mohamed ASR; Lai SY; Fuller CD; Rosenthal DI NPJ Precis Oncol; 2019; 3():22. PubMed ID: 31583278 [TBL] [Abstract][Full Text] [Related]
60. Second Primary Malignancies in Adults with Gastric Cancer - A US Population-Based Study. Shah BK; Khanal A; Hewett Y Front Oncol; 2016; 6():82. PubMed ID: 27148474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]